Alex M. Azar II has served as a member of Guardant Health's Board since September 2025 and serves on the Nominating and Corporate Governance Committee.
Secretary Azar served as the 24th Secretary of the U.S. Department of Health and Human Services (HHS) from 2018 to 2021. Prior to his appointment as HHS Secretary, he held multiple executive leadership roles including President of Lilly USA, LLC, the largest affiliate of Eli Lilly and Company, from 2007 to 2017; Deputy Secretary of HHS from 2005 to 2007; General Counsel of HHS from 2001 to 2005; and Partner at Wiley Rein LLP from 1999 to 2001.
He currently serves as an Adjunct Professor of Business and Distinguished Executive-in-Residence at the University of Miami Herbert Business School. Secretary Azar is a member of the Board of Trustees at the Aspen Institute, chairman of the board of the Healthcare Leadership Council, chairman of the board of LifeScience Logistics, a member of the boards of Global Health/MCS and AbsoluteCare, an advisor at Foresite Capital, a member of the advisory board of Milken Institute's FasterCures, and a member of the Department of Health Policy Advisory Board at the Stanford University School of Medicine. He received a Bachelor of Arts in Government and Economics from Dartmouth College and a J.D. from Yale Law School.